Christina Binder, MD
Radiation Oncology · Durango, CONPI 1922412485
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $240 of the $289 with a category attached, or 83.1%. 5 manufacturers reported payments, led by Pfizer at 35.3% of the total. Reporting peaked in 2024 at $142 and has fallen 76.6% since, to $33 in 2025. That places this record below the midpoint for radiation oncology clinicians in CO, where the typical reported total is $456.
Across 11 payments — averaging $26.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$102
- Siemens Medical Solutions USA, Inc.$87
- Myriad Genetic Laboratories, Inc.$67
- Sumitomo Pharma America, Inc.$17
- Tactile Systems Technology Inc$16
What the payments were for
- Food & beverage$24083%
- Education$4917%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 6 | $102 |
| Siemens Medical Solutions USA, Inc. | 2 | $87 |
| Myriad Genetic Laboratories, Inc. | 1 | $67 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $16 |
How this compares
$289 in reported general payments places this provider in the 30th percentile of 105 radiation oncology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 70 | $649 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Durango
- Jonathan ClarkDurango$7K
- Brock BakerDurango$369
- Peter RossiGlenwood Springs$146K
- Suraj SinghGreely$134K
- Meera PatelAurora$112K
- David RabenAurora$61K
- Dustin BootheGreeley$55K
- Kevin ScheweThornton$51K
- Christine FisherAurora$28K
- Thomas PughDenver$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.